Proxima (Drug Discovery) Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $91.5M

  • Investors
  • 10

Proxima (Drug Discovery) General Information

Description

Developer of precision-engineered bioreactor systems intended to enable sustainable protein production through cellular agriculture. The company designs and builds modular bioprocessing equipment with integrated control systems, scalable architecture, monitoring capabilities and compatibility with diverse cell lines, offering automated nutrient delivery, real-time data analytics and optimized growth environments, enabling cultivated meat and alternative protein producers to achieve consistent yields, reduce operational complexity and accelerate commercialization while meeting stringent food safety and regulatory standards.

Contact Information

Website
www.proximabio.com
Formerly Known As
VantAI, Proxima Bio Holdings, Vant AI Holdings
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 116 East 16th Street
  • 12th Floor
  • New York, NY 10003
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
AgTech, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • 116 East 16th Street
  • 12th Floor
  • New York, NY 10003
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Proxima (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 09-Jun-2026 $91.5M Completed Generating Revenue
To view Proxima (Drug Discovery)’s complete valuation and funding history, request access »

Proxima (Drug Discovery) Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
AIX Ventures Venture Capital Minority
Alexandria Venture Investments Venture Capital Minority
Braidwell Hedge Fund Minority
DCVC Venture Capital Minority
Magnetic Ventures Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Proxima (Drug Discovery) FAQs

  • When was Proxima (Drug Discovery) founded?

    Proxima (Drug Discovery) was founded in 2019.

  • Where is Proxima (Drug Discovery) headquartered?

    Proxima (Drug Discovery) is headquartered in New York, NY.

  • What industry is Proxima (Drug Discovery) in?

    Proxima (Drug Discovery)’s primary industry is Drug Discovery.

  • Is Proxima (Drug Discovery) a private or public company?

    Proxima (Drug Discovery) is a Private company.

  • What is Proxima (Drug Discovery)’s current revenue?

    The current revenue for Proxima (Drug Discovery) is .

  • How much funding has Proxima (Drug Discovery) raised over time?

    Proxima (Drug Discovery) has raised $91.5M.

  • Who are Proxima (Drug Discovery)’s investors?

    AIX Ventures, Alexandria Venture Investments, Braidwell, DCVC, and Magnetic Ventures are 5 of 10 investors who have invested in Proxima (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process